Recent Funding Boost Alpine Immune Sciences recently raised $150 million through a public offering, indicating strong investor confidence and significant financial resources that could support expansion into new research areas or geographic markets.
Strategic Alliance The company's partnership with AbbVie on the acazicolcept license suggests opportunities for joint development and commercialization efforts, making it a prime target for collaboration and licensing solutions.
Expanding Leadership The appointment of key executives such as a new Chief Medical Officer and Chief Accounting Officer demonstrates ongoing organizational growth, which could lead to increased demand for consulting, compliance, and operational support services.
Market Positioning As a biotechnology company with a focus on immunotherapy and recent public market activity, Alpine Immune Sciences may seek innovative technology solutions to accelerate clinical trials and enhance data management capabilities.
Industry Focus Being part of the pharmaceutical and biotech sector with connections to Vertex Pharmaceuticals provides opportunities to offer specialized biotech R&D tools, regulatory advisory services, and market expansion solutions tailored for advanced biotech enterprises.
Alpine Immune Sciences, Inc. uses 8 technology products and services including cdnjs, RSS, Twemoji, and more. Explore Alpine Immune Sciences, Inc.'s tech stack below.
| Alpine Immune Sciences, Inc. Email Formats | Percentage |
| First.Last@alpineimmunesciences.com | 46% |
| FLast@alpineimmunesciences.com | 4% |
| First.Last@alpineimmunesciences.com | 46% |
| FLast@alpineimmunesciences.com | 4% |
Biotechnology ResearchWashington, United States51-200 Employees
Alpine Immune Sciences is now part of Vertex Pharmaceuticals. Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. For more information about Vertex, please visit us at https://www.vrtx.com/. Follow Vertex on LinkedIn for future updates at https://www.linkedin.com/company/vertex-pharmaceuticals/.
Company Overview
Media & News
Funding & FinancialsAlpine Immune Sciences, Inc. has raised a total of $150M of funding over 7 rounds. Their latest funding round was raised on Nov 06, 2023 in the amount of $150M.
Alpine Immune Sciences, Inc.'s revenue is estimated to be in the range of $10M$25M
Funding & FinancialsAlpine Immune Sciences, Inc. has raised a total of $150M of funding over 7 rounds. Their latest funding round was raised on Nov 06, 2023 in the amount of $150M.
Alpine Immune Sciences, Inc.'s revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com